BioLife Solutions, Inc.
BLFS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,196 | $710 | $773 | $1,435 |
| - Cash | $95 | $35 | $19 | $70 |
| + Debt | $30 | $43 | $44 | $27 |
| Enterprise Value | $1,131 | $718 | $797 | $1,392 |
| Revenue | $82 | $143 | $76 | $119 |
| % Growth | -42.6% | 87.9% | -36% | – |
| Gross Profit | $54 | $47 | $54 | $38 |
| % Margin | 65.3% | 32.6% | 70.6% | 31.7% |
| EBITDA | $2 | -$45 | -$124 | -$17 |
| % Margin | 1.9% | -31.6% | -162.9% | -14% |
| Net Income | -$20 | -$66 | -$140 | -$9 |
| % Margin | -24.5% | -46.4% | -183.4% | -7.5% |
| EPS Diluted | -0.44 | -1.52 | -3.29 | -0.23 |
| % Growth | 71.1% | 53.8% | -1,330.4% | – |
| Operating Cash Flow | $8 | -$12 | -$8 | -$5 |
| Capital Expenditures | -$3 | -$6 | -$10 | -$8 |
| Free Cash Flow | $5 | -$19 | -$19 | -$13 |